Risk of endocrine complications in cancer patients treated with immune check point inhibitors: a meta-analysis

Future Oncology
Omar Abdel-RahmanMona Fouad

Abstract

We performed a meta-analysis of the risk of endocrine adverse events associated with immune check point inhibitors. Eligible studies included randomized trials of cancer patients on immune checkpoint inhibitors; describing events of hypothyroidism, hyperthyroidism, hypophysitis and adrenal insufficiency. A total of ten clinical trials were eligible for the meta-analysis. The relative risk of all-grade hypothyroidism, hyperthyroidism, hypophyisitis and adrenal insufficiency were 8.26 (95% CI: 4.67-14.62; p < 0.00001), 5.48 (95% CI: 1.33-22.53; p = 0.02); 22.03 (95% CI: 8.52-56.94; p < 0.00001), 3.87 (95% CI: 1.12-13.41; p = 0.03), respectively. Our meta-analysis has demonstrated that the use of immune check point inhibitors is associated with an increased risk of hypothyroidism, hyperthyroidism, hypophysitis and adrenal insufficiency compared with control.

References

Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
May 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Raanan BergerArnon Nagler
Jul 23, 2009·Annals of Internal Medicine·David MoherUNKNOWN PRISMA Group
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Jun 7, 2011·The New England Journal of Medicine·Caroline RobertJedd D Wolchok
May 2, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas J LynchMartin Reck
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Jun 5, 2012·The New England Journal of Medicine·Julie R BrahmerJon M Wigginton
Jan 9, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antoni RibasAxel Hauschild
Mar 9, 2013·The Journal of Clinical Endocrinology and Metabolism·Salvatore Maria CorselloFrancesco Torino
Apr 30, 2013·Journal of Leukocyte Biology·Andrew M Intlekofer, Craig B Thompson
Jun 4, 2013·The New England Journal of Medicine·Omid HamidAntoni Ribas
Sep 5, 2013·European Journal of Endocrinology·Francesco TorinoSalvatore Maria Corsello
Oct 15, 2013·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·A LammertC Berking
Apr 4, 2014·Science Translational Medicine·Shintaro IwamaPatrizio Caturegli
Aug 1, 2014·The Journal of Clinical Endocrinology and Metabolism·Alexander T FajeLisa Nachtigall
Aug 16, 2014·Clinical Neurology and Neurosurgery·Yosef ChodakiewitzJeffrey M Rogg
Nov 18, 2014·The New England Journal of Medicine·Caroline RobertPaolo A Ascierto
Nov 25, 2014·European Journal of Endocrinology·Frédérique AlbarelThierry Brue
Dec 30, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Le MinUrsula B Kaiser
Apr 22, 2015·The New England Journal of Medicine·Caroline RobertUNKNOWN KEYNOTE-006 investigators
Apr 22, 2015·The New England Journal of Medicine·Michael A PostowF Stephen Hodi
Jun 2, 2015·The New England Journal of Medicine·James LarkinJedd D Wolchok
Jun 2, 2015·The New England Journal of Medicine·Julie BrahmerDavid R Spigel

❮ Previous
Next ❯

Citations

May 3, 2016·Current Opinion in Oncology·Francesco TorinoRoberto Salvatori
Jun 25, 2016·Clinical Oncology : a Journal of the Royal College of Radiologists·O Abdel-RahmanH Oweira
May 14, 2016·Clinical Pharmacology and Therapeutics·K A MarroneJ Naidoo
Oct 26, 2016·Expert Review of Anticancer Therapy·Pol Specenier
Mar 30, 2017·Expert Opinion on Drug Safety·Carlo GenovaFrancesco Grossi
Mar 6, 2016·Therapeutic Advances in Respiratory Disease·Omar Abdel-Rahman, Mona Fouad
Mar 7, 2017·International Journal of Cancer. Journal International Du Cancer·Wenjun WangJianxing He
Mar 22, 2018·Expert Review of Anticancer Therapy·Pol Specenier
Mar 10, 2018·Cancer Science·Touko AsanoYoshihiro Komohara
Oct 5, 2018·Modern Rheumatology·Kei OhnumaChikao Morimoto
Dec 12, 2018·Journal of Molecular Endocrinology·Afreen Idris ShariffLeonor Corsino
May 30, 2019·International Journal of Molecular Sciences·Silvia Martina FerrariAlessandro Antonelli
Jan 11, 2018·The New England Journal of Medicine·Michael A PostowMatthew D Hellmann
Jun 4, 2017·The Oncologist·Jarushka NaidooJulie R Brahmer
Oct 3, 2018·American Journal of Therapeutics·Tushar MishraMariam Hazem
Apr 17, 2020·Diagnostics·Vanina VaniEmanuele Neri
Apr 30, 2020·Immunotherapy·Maria V DeligiorgiDimitrios T Trafalis
Dec 22, 2017·Journal of the Endocrine Society·Anne-Cécile PaepegaeyLionel Groussin
Aug 31, 2018·Canadian Journal of Gastroenterology & Hepatology·Omar Abdel-Rahman, Winson Y Cheung
Jul 12, 2019·Frontiers in Oncology·Caoilfhionn ConnollyJarushka Naidoo
Dec 22, 2016·Immunotherapy·Mahmoud A AliOmar Abdel-Rahman
Mar 19, 2019·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Eric D JohnsonShiven B Patel
Aug 20, 2018·Current Neurology and Neuroscience Reports·Adam LaukoManmeet S Ahluwalia
Jul 20, 2019·Journal of Endocrinological Investigation·C BetterleJ Furmaniak
Oct 19, 2017·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Grenye O'MalleyEmily J Gallagher
Dec 15, 2017·Journal of Endocrinological Investigation·P ChalanP Caturegli
Oct 14, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Georgios ChamilosDimitrios P Kontoyiannis
Jul 28, 2019·Trends in Endocrinology and Metabolism : TEM·Sabrina ChiloiroLaura De Marinis
Oct 9, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Yi-He LiuPeng Zhang
Apr 4, 2020·International Immunopharmacology·Maria V DeligiorgiDimitrios T Trafalis
Apr 8, 2019·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Elisa GuerreroJoe-Elie Salem

❮ Previous
Next ❯

Software Mentioned

Google scholar
Review Manager

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.